Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575809 · ClinicalTrials.gov registry record
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
A clinical trial of Peripheral Blood Stem Cell Transplantation, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 633
- Enrollment target
- 2
- Study locations
NCT00575809 is a study of Peripheral Blood Stem Cell Transplantation that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 633 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT00575809, a study of Peripheral Blood Stem Cell Transplantation, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 633 participants
- Enrollment target
- 2
- Study locations
Study Summary
Our study intends to evaluate prospectively the incidence and severity of oral mucositis in patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, as well as to evaluate the potential influence of nutritional-, physical-, and transplant-related factors associated with the development of this complication and its grade of involvement.
Conditions Studied
Interventions
- OTHER Mucositis and nutritional assessments
Study Locations (2)
Texas
- Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division - San Antonio
- The University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 633 participants |
| Start Date | 2005-05 |
| Est. Completion | 2021-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00575809
The ClinicalTrials.gov registry entry for NCT00575809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 633 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Blood Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Mucositis and nutritional assessments is the first listed.
NCT00575809 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00575809 about?
NCT00575809 is a clinical study titled "Incidence and Factors Associated With the Development and Severity of Oral Mucositis". Our study intends to evaluate prospectively the incidence and severity of oral mucositis in patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, as well as to evaluate the potential influence of nutritional-, physical-, and transplant-related factors associated wit...
What is the current status of trial NCT00575809?
This trial is currently completed. The enrollment target is 633 participants. The study started on 2005-05. Estimated completion is 2021-07-15.
What conditions does trial NCT00575809 study?
This clinical trial studies the following conditions: Peripheral Blood Stem Cell Transplantation.
What interventions are being tested in trial NCT00575809?
The interventions under investigation include: Mucositis and nutritional assessments (OTHER).
Who is sponsoring clinical trial NCT00575809?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00575809 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Blood Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RECRUITING · Phase 1
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.